 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is our internal ID - starting with VT.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
- For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
 |
 |
 |
 |
 |
Keywords: |
 |
|
 |
 |
 |
 |
Phase: |
 |
Phase 3 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT1923
NCT00096265
|
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
70: Cares for self, unable to perform normal activity or to do active work |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed:
Recurrent:
Prior Surgery is Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Allowed Histologically confirmed non-small cell lung cancer
One to 3 intraparenchymal brain metastases by contrast-enhanced MRI, meeting the following criteria:
Well circumscribed tumor(s)
Maximum diameter = 4.0 cm
If multiple lesions are present and one lesion is at the maximum diameter, the other lesions must be = 3.0 cm in maximum diameter
No metastases within 10 mm of the optic apparatus such that a portion of the optic nerve or chiasm would be included in the high-dose stereotactic radiosurgery boost field
No metastases in the brainstem, midbrain, pons, or medulla
No prior complete resection of all known brain metastases
Subtotal resection allowed provided residual disease is = 4.0 cm in maximum diameter
No clinical or radiographic evidence of progression (other than study lesion[s]) within the past month
Patients with brain metastases at initial presentation do not require 1 month of scans documenting stable disease
Stable extracranial metastases allowed
Extent of extracranial metastases documented by contrast-enhancing CT scans of the chest, abdomen, and pelvis AND bone scan
No liver metastases
No leptomeningeal metastases by MRI or cerebrospinal fluid evaluation
|
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
05/20/2009 |
 |
 |
 |
 |
Tumor Types: |
 |
Metastatic Brain Tumor |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Radiation. |
 |
 |
 |
 |
Contact: |
 |
South Nassau Communities Hospital LI Gamma Knife Center Donna Moeller, RN,OCN Gamma Knife Patient Coordinator 1 Healthy Way Oceanside, NY 11572 Phone:5166323366 Fax: 5163362930 Click here to send an email Website: ligamma.org |
 |
 |
|
|